Stock Quotes in this Article: ASTM, CJJD, CRME, OTIV, OXGN

DELAFIELD, Wis. (Stockpickr) -- There isn't a day that goes by on Wall Street when certain stocks trading for $10 a share or less don't experience massive spikes higher. Traders savvy enough to follow the low-priced names and trade them with discipline and sound risk management are banking ridiculous coin on a regular basis.

>>5 Big Trades to Take This Year

Just take a look at some of the hot movers in the under-$10 complex from Thursday, including Prospect Global Resources (PGRX), which is skyrocketing higher by 30%; Cardica (CRDC), which is soaring higher by 27%; Clean Diesel Technologies (CDTI), which is ripping higher by around 20%; and Zion Oil & Gas (ZN), which is spiking higher by 16%. You don't even have to catch the entire move in lower-priced stocks such as these to make outsized returns when trading.

One low-priced stock that recently spiked huge after I featured it was biopharmaceutical player Zalicus (ZLCS), which I highlighted in Jan. 3's "5 Stocks Poised for Breakouts" at $1.27 per share. I mentioned in that piece that shares of Zalicus of were starting to spike higher and take out some near-term overhead resistance at $1.22 a share. That move was quickly pushing the stock within range of triggering a major breakout trade above some key overhead resistance levels at $1.43 to $1.45 a share.

>>5 Stocks Insiders Love Right Now

Guess what happened? Shares of Zalicus didn't wait long to trigger that breakout, since the stock exploded higher on Jan. 8 with monster upside volume. This stock went on to tag an intraday high of $2 a share on that day, which represents a monster gain of over 50% for anyone who bought the stock around the levels from my original article. As you can see here, when trading lower-priced stocks the gains can be incredible when we key overhead resistance levels are taken out with volume.

>>4 Stocks Triggering Breakouts on Unusual Volume

Low-priced stocks are something that I tweet about on a regular basis. I frequently flag high-probability setups, breakout candidates and low-priced stocks that are acting technically bullish. I like to hunt for low-priced stocks that are showing bullish price and volume trends, since that increases the probability of those stocks heading higher. These setups often produce monster moves higher in very short time frames.

I'm not as eager to recommend investing long-term in stocks that trade less than $10 a share because these names can be very speculative, and the odds for picking the long-term winners aren't great. But I definitely love to trade stocks that are priced below $10. I like to view them as a trading vehicle with lots of volatility and lots of upside when the trade is timed right.

>>Invest Like a Venture Capitalist With These 5 Stocks

When I trade under-$10 names, I do it almost entirely based off of the charts and technical analysis. I also like to find under-$10 names with a catalyst, but that's secondary to the chart and volume patterns.

With that in mind, here's a look at several under-$10 stocks that look poised to potentially trade higher from current levels.

Cardiome Pharma

 

 

 

One under-$10 biopharmaceutical player that's starting to move within range of triggering a big breakout trade is Cardiome Pharma (CRME), which engages in the discovery, development and commercialization of therapies that enhance the health of patients. This stock has been on fire over the last three months, with shares up sharply by 43%.

>>5 Toxic Stocks to Sell in 2014

If you take a look at the chart for Cardiome Pharma, you'll notice that this stock has been trading range bound for the last month or so, with shares moving between $5.85 on the downside and $7.15 on the upside. Shares of CRME have now started to bounce higher off that big support level near $6 a share and it's quickly moving within range of triggering a big breakout trade above some key near-term overhead resistance levels.

Traders should now look for long-biased trades in CRME if it manages to break out above some near-term overhead resistance levels at $6.95 to its 52-week high at $7.15 a share with high volume. Look for a sustained move or close above those levels with volume that hits near or above its three-month average volume of 123,602 shares. If that breakout triggers soon, then CRME will set up to enter new 52-week-high territory, which is bullish technical price action. Some possible upside targets off that breakout are $9 to $10 a share.

Traders can look to buy CRME off any weakness to anticipate that breakout and simply use a stop that sits right below some key near-term support levels at $6 or $5.85 or near its 50-day moving average of $5.63 a share. One can also buy CRME off strength once it starts to take out those breakout levels with volume and then simply use a stop that sits a comfortable percentage from your entry point.

Aastrom Biosciences

 

 

Another under-$10 biopharmaceutical player that's starting to move within range of triggering a big breakout trade is Aastrom Biosciences (ASTM), which is a regenerative medicine company focused on the development of cell therapies to repair or regenerate damaged or diseased tissues. This stock has trended modestly lower over the last three months, with shares off by 4.9%.

>>5 Stocks Set to Soar on Bullish Earnings

If you take a look at the chart for Aastrom Biosciences, you'll notice that this stock just recently formed a double bottom chart pattern at $3.16 to $3.14 a share over the last month and change. Following that bottom, shares of ASTM have started to spike higher and move back above its 50-day moving average of $3.58 a share. That move is quickly pushing shares of ASTM within range of triggering a big breakout trade.

Market players should now look for long-biased trades in ASTM if it manages to break out above some near-term overhead resistance at $4.50 a share with high volume. Look for a sustained move or close above that level with volume that hits near or above its three-month average action of 140,540 shares. If that breakout hits soon, then ASTM will set up to re-test or possibly take out its next major overhead resistance levels at $6.25 to $6.80 a share. Any high-volume move above those levels will then give ASTM a chance to re-fill some of its previous gap-down-zone from last August that started at $12 a share.

Traders can look to buy ASTM off any weakness to anticipate that breakout and simply use a stop that sits right below its 50-day moving average of $3.58 a share. One can also buy ASTM off strength once it starts to clear $4.50 a share with volume and then simply use a stop that sits a comfortable percentage from your entry point.

On Track Innovations

 

 

One under-$10 technology player that's starting to trend within range of triggering a major breakout trade is On Track Innovations (OTIV), which designs, develops and markets contactless microprocessor-based smart card solutions to customers in Africa, Europe, the Far East, the Americas and Israel. This stock has been red hot over the last three months, with shares up a whopping 134%.

>>5 Rocket Stocks to Buy for Repeat Gains in 2014

If you take a look at the chart for On Track Innovations, you'll notice that this stock has been trending sideways and consolidating over the last month and change, with shares moving between $2.70 on the downside and $3.74 on the upside. Shares of OTIV have now started to spike higher off some near-term support at $3 a share and it's quickly moving within range of triggering a major breakout trade above the upper-end of its recent sideways trading chart pattern.

Traders should now look for long-biased trades in OTIV if it manages to break out above its 52-week high at $3.74 a share with high volume. Look for a sustained move or close above that level with volume that hits near or above its three-month average volume of 626,538 shares. If that breakout triggers soon, then OTIV will set up to enter new 52-week-high territory, which is bullish technical price action. Some possible upside targets off that breakout are $4.50 to $5.50 a share.

Traders can look to buy OTIV off weakness to anticipate that breakout and simply use a stop that sits just below some key near-term support levels at $3.20 or at $3 a share. One can also buy OTIV off strength once it starts to clear its 52-week high at $3.74 a share with volume and then simply use a stop that sits a comfortable percentage from your entry point.

China Jo-Jo Drugstores

 

 

Another under-$10 drug retailer that's starting to move within range of triggering a big breakout trade is China Jo-Jo Drugstores (CJJD), which operates as a retailer and distributor of pharmaceutical and other health care products in the People's Republic of China. This stock has been on fire for the last three months, with shares ripping higher by 46%.

>>5 Stocks Rising on Unusual Volume

If you take a look at the chart for China Jo-Jo Drugstores you'll notice that this stock has been uptrending strong over the last month and change, with shares moving higher from its low of 65 cents per share to its recent high of $1.18 a share. During that uptrend, shares of CJJD have been making mostly higher lows and higher highs, which is bullish technical price action. That move has now pushed shares of CJJD within range of triggering a big breakout trade above some near-term and past overhead resistance levels.

Market players should now look for long-biased trades in CJJD if it manages to break out above some near-term overhead resistance at $1.18 a share and then once it clears some past overhead resistance levels at $1.21 to $1.32 a share high volume. Look for a sustained move or close above those levels with volume that hits near or above its three-month average action of 99,122 shares. If that breakout hits soon, then CJJD will set up to re-test or possibly take out its next major overhead resistance levels at $1.70 to its 52-week high at $1.99 a share.

Traders can look to buy CJJD off weakness to anticipate that breakout and simply use a stop that sits just below its 50-day moving average of 98 cents per share. One can also buy CJJD off strength once it starts to clear those breakout levels with volume and then simply use a stop that sits a comfortable percentage from your entry point.

Oxigene

 

 

One final under-$10 biopharmaceutical player that's starting to trend within range of triggering a near-term breakout trade is Oxigene (OXGN), which develops therapeutics primarily to treat cancer. This stock is up modestly over the last three months, with shares up by 2.9%.

If you take a look at the chart for Oxigene, you'll notice that this recently put in a double bottom chart pattern at $2.33 to $2.34 a share. Following that bottom, shares of OXGN have started to uptrend and move back above its 50-day moving average of $2.70 a share. That move is quickly pushing shares of OXGN within range of triggering a near-term breakout trade above some key overhead resistance levels.

Traders should now look for long-biased trades in OXGN if it manages to break out above its 200-day moving average of $2.85 a share and then once it takes out some near-term overhead resistance at $2.92 a share with high volume. Look for a sustained move or close above those levels with volume that hits near or above its three-month average action of 547,140 shares. If that breakout hits soon, then OXGN will set up to re-test or possibly take out its next major overhead resistance levels at $3.48 to $4 a share. Any high-volume move above those levels will then give OXGN a chance to tag its next major overhead resistance levels at $4.58 a share.

Traders can look to buy OXGN off weakness to anticipate that breakout and simply use a stop that sits right below that double bottom support zone at $2.34 to $2.33 a share. One can also buy OXGN off strength once it starts to take out those breakout levels with volume and then simply use a stop that sits a comfortable percentage from your entry point.

To see more hot under-$10 equities, check out the Stocks Under $10 Setting Up to Explode portfolio on Stockpickr.

-- Written by Roberto Pedone in Delafield, Wis.

 

RELATED LINKS:

 

Follow Stockpickr on Twitter and become a fan on Facebook.

At the time of publication, author had no positions in stocks mentioned.

Roberto Pedone, based out of Delafield, Wis., is an independent trader who focuses on technical analysis for small- and large-cap stocks, options, futures, commodities and currencies. Roberto studied international business at the Milwaukee School of Engineering, and he spent a year overseas studying business in Lubeck, Germany. His work has appeared on financial outlets including CNBC.com and Forbes.com.

You can follow Pedone on Twitter at www.twitter.com/zerosum24 or @zerosum24.